Physician profile
Ami A Epstein
NPI 1962478727
$7,720.33
in general payments reported to CMS, 2019-2025
11 companies · $851 in 2025
The $851 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,433 · 2020: $200 · 2021: $534 · 2022: $825 · 2023: $1,006 · 2024: $1,872 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041 · Travel and Lodging: $1,238 · Consulting Fee: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.87 |
| Travel and Lodging | $1,237.77 |
| Consulting Fee | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,720.91 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,207.11 | 2019-2021 | |
| Alcon Vision LLC | $1,344.65 | 2019-2025 | Air Optix, Simbrinza, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $610.05 | 2019-2025 | Acuvue |
| Coopervision INC. | $344.90 | 2019-2025 | Clariti Contact Lens |
| Glaukos Corporation | $159.95 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $118.80 | 2025 | |
| Harrow Eye, LLC | $100.32 | 2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $55.67 | 2022 | |
| Allergan, INC. | $45.80 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.